C

Cardiff Oncology
D

CRDF

4.74000
USD
0.04
(0.85%)
Market Closed
Volume
31,388
EPS
-1
Div Yield
-
P/E
-5
Market Cap
315,324,623
OverviewSignalsIdeasNews
Related Instruments
    B
    BLNK
    -0.03500
    (-3.30%)
    1.02500 USD
    H
    HYLN
    -0.11000
    (-5.45%)
    1.91000 USD
    LI
    LI
    1.090
    (4.13%)
    27.470 USD
    N
    NIO
    0.07500
    (1.72%)
    4.44500 USD
    P
    PLUG
    -0.09500
    (-5.43%)
    1.65500 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    W
    WKHS
    -0.03210
    (-6.20%)
    0.48580 USD
    X
    XPEV
    0.730
    (4.13%)
    18.425 USD
    More
News

Title: Cardiff Oncology

Sector: Healthcare
Industry: Biotechnology
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.